WO2020200830A1 - Distributeur d'aérosol réglable destiné à un appareil de ventilation et appareil de ventilation comportant ce dernier - Google Patents

Distributeur d'aérosol réglable destiné à un appareil de ventilation et appareil de ventilation comportant ce dernier Download PDF

Info

Publication number
WO2020200830A1
WO2020200830A1 PCT/EP2020/057701 EP2020057701W WO2020200830A1 WO 2020200830 A1 WO2020200830 A1 WO 2020200830A1 EP 2020057701 W EP2020057701 W EP 2020057701W WO 2020200830 A1 WO2020200830 A1 WO 2020200830A1
Authority
WO
WIPO (PCT)
Prior art keywords
cartridge
opening
aerosol dispenser
housing
active ingredient
Prior art date
Application number
PCT/EP2020/057701
Other languages
German (de)
English (en)
Inventor
Stengl ANDREAS
Original Assignee
Andreas Stengl
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Andreas Stengl filed Critical Andreas Stengl
Publication of WO2020200830A1 publication Critical patent/WO2020200830A1/fr

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M11/00—Sprayers or atomisers specially adapted for therapeutic purposes
    • A61M11/04—Sprayers or atomisers specially adapted for therapeutic purposes operated by the vapour pressure of the liquid to be sprayed or atomised
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M11/00—Sprayers or atomisers specially adapted for therapeutic purposes
    • A61M11/02—Sprayers or atomisers specially adapted for therapeutic purposes operated by air or other gas pressure applied to the liquid or other product to be sprayed or atomised
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M16/00—Devices for influencing the respiratory system of patients by gas treatment, e.g. mouth-to-mouth respiration; Tracheal tubes
    • A61M16/10—Preparation of respiratory gases or vapours
    • A61M16/14—Preparation of respiratory gases or vapours by mixing different fluids, one of them being in a liquid phase
    • A61M16/142—Preparation of respiratory gases or vapours by mixing different fluids, one of them being in a liquid phase with semi-permeable walls separating the liquid from the respiratory gas
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M16/00—Devices for influencing the respiratory system of patients by gas treatment, e.g. mouth-to-mouth respiration; Tracheal tubes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M16/00—Devices for influencing the respiratory system of patients by gas treatment, e.g. mouth-to-mouth respiration; Tracheal tubes
    • A61M16/08—Bellows; Connecting tubes ; Water traps; Patient circuits
    • A61M16/0875—Connecting tubes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M2202/00—Special media to be introduced, removed or treated
    • A61M2202/04—Liquids
    • A61M2202/0468—Liquids non-physiological
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M2205/00—General characteristics of the apparatus
    • A61M2205/12—General characteristics of the apparatus with interchangeable cassettes forming partially or totally the fluid circuit
    • A61M2205/123—General characteristics of the apparatus with interchangeable cassettes forming partially or totally the fluid circuit with incorporated reservoirs

Definitions

  • the present invention relates to an aerosol dispenser for a ventilator, in particular an adjustable aerosol dispenser for a ventilator, and a ventilator with the same.
  • Ventilators are well known medical devices that allow patients to be ventilated. They are used, for example, in emergency or intensive medicine.
  • various nebulisers are available on the market for ventilation systems of this type, which can be coupled to the ventilation tubes in order to simultaneously supply a patient with an active ingredient in aerosol form via the breathing tube of the ventilation system.
  • nebulizer units use ultrasound or a vibrating membrane provided with openings (oscillating membrane), which is vibrated by a piezo element, for example, in order to generate an aerosol from an active ingredient solution, which can be supplied to the patient via the inhaled air.
  • such nebulizer units require an external power supply and complex control electronics and should therefore only be used by trained medical personnel.
  • CPAP ventilation therapy (CPAP stands for “continuous positive airway pressure”), which continuously generates an overpressure that makes it easier to breathe in.
  • Fibers can be used for drug nebulization in CPAP therapy. These have a T-piece that is attached between a breathing mask worn by the patient and the CPAP machine, the straight part of which is connected to the ventilation tubes. Essentially perpendicular to this, the bubble nebulizer has a connector for attaching a solution reservoir on. The liquid is atomized by the air flowing through it. Because the aerosol is introduced essentially vertically into the main ventilation air flow, the aerosol can be undesirably deposited at the corresponding junction, thereby impairing the efficiency of the drug administration. In addition, such nebulizers, in particular because of the proper handling and attachment of the drug reservoir, should also be used only by medical professionals.
  • CPAP ventilation therapy can be used in the treatment of chronic obstructive pulmonary disease (COPD), such as chronic obstructive bronchitis or emphysema, or sleep apnea can be used.
  • COPD chronic obstructive pulmonary disease
  • Mild respiratory diseases make ventilation therapy of this kind, carried out independently by the patient at home, more difficult, for example CPAP ventilation overnight in the therapy of sleep apnea.
  • the object of the present invention is to provide a novel aerosol dispenser for a ventilator, which is inexpensive to manufacture and easy and user-friendly to use, and a corresponding ventilator to eliminate or at least reduce the deficiencies known in the prior art.
  • the invention proposes an adjustable aerosol dispenser for a ventilator, which is suitable for the application of an active ingredient in the airways by means of a ventilator, the aerosol dispenser according to the invention comprising an active ingredient reservoir and a housing.
  • the housing is a hollow body which has an air inlet opening and an air outlet opening opposite the air inlet opening, the air inlet opening and the air outlet opening each being configured for coupling to a breathing tube.
  • the air inlet opening and the air outlet opening communicate with the active substance reservoir, so that ventilation air can flow past the active substance reservoir in the housing and / or can flow through it.
  • the active substance reservoir is an exchangeable cartridge, which preferably has a substantially cylindrical basic shape with two end faces and a lateral surface and defines an active substance receiving space inside for receiving an active substance to be released into the ventilation air, the cartridge in particular having a cartridge opening on the lateral surface of the cartridge has, which serves to provide the active ingredient from the active ingredient reservoir for the ventilation air flow.
  • the cartridge opening can be completely or partially closed by a closure device, so that the dosage of the active ingredient can be adjusted.
  • the partial closure of the cartridge opening can take place gradually with discrete closure degrees or continuously with any desired degree of closure.
  • a drug reservoir receptacle is provided in the housing of the aerosol dispenser, which is configured to attach the drug reservoir or the cartridge.
  • the drug reservoir receptacle can be formed out by a zy cylinder-shaped space with two end faces and a lateral surface in the housing, which can be tightly closed to the outside of the housing, wherein the drug reservoir receptacle can be limited by a peripheral wall that extends along the lateral surface and has a peripheral wall opening, where the active ingredient reservoir receptacle is in communication through the peripheral wall opening with the inner space of the housing.
  • the cartridge opening which can preferably be formed in the jacket surface in the case of the cylindrical configuration of the cartridge, can extend essentially over the entire height of the cartridge from one end face to the other and / or evenly over a circular sector along the jacket surface.
  • An active substance carrier can be accommodated in the active substance receiving space of the cartridge, wherein in particular the active substance carrier can be a solid carrier matrix impregnated with an active substance solution.
  • the cartridge can be accommodated in the active ingredient reservoir so that it can rotate about the longitudinal axis of the cylinder.
  • the order of the peripheral wall opening similar to the cartridge opening, can extend over the entire height of the active ingredient reservoir receptacle from one end face to the other and / or evenly over a circular sector along the lateral surface, the cartridge opening can be partially or completely removed by rotating the cartridge Peripheral wall opening can be covered so that the freely accessible opening to the active ingredient receiving space varies and thus the delivery dose for the active ingredient can be changed.
  • the peripheral wall can also be designed to be rotatable about the longitudinal axis of the cylinder.
  • An opening angle or central angle of the cartridge opening and / or the peripheral wall opening can be up to a maximum of 180 °, the angle in particular between 30 ° and 120 °, preferably between 60 ° and 90 °.
  • the housing can be a substantially cylindrical or rectangular body.
  • the air inlet opening and the air outlet opening can be formed on two opposite sides of the housing, wherein an air flow direction is defined from the air inlet opening in the direction of the air outlet opening inside the hollow body along the length of the housing, the cylindrical space of the active ingredient reservoir receptacle can extend parallel to the air flow direction.
  • guide elements such as air baffles, can be provided between the air inlet opening and the air outlet opening, which can for example be arranged in a spiral around the active ingredient reservoir receptacle in order to forcibly guide the air over a wide and in particular the entire area of the peripheral wall opening or cartridge opening, whereby the air flow can be guided past the respective openings several times.
  • the cylindrical space of the active substance reservoir receptacle can be provided at least one end with an opening towards the outside in order to enable the active substance reservoir to be inserted into the active substance reservoir receptacle or to be removed therefrom.
  • the active substance reservoir receptacle can have an upper opening and / or a lower opening, the at least one opening being closable by an airtight element.
  • the airtight element can be configured as a rotating element, the rotating element being rotatable relative to the housing and being able to rotate with a cartridge received in the active substance reservoir receptacle.
  • the cylindrical space of the active substance reservoir receptacle can be open to the outside at both ends.
  • the drug reservoir receptacle can extend along the entire length of the housing and have an upper opening at the upper end and a lower opening at the lower end.
  • the upper opening can preferably be closed by the rotary element, wherein the lower opening can be tightly closed by another airtight element, namely a detachable closure cover.
  • each of the openings of the active ingredient reservoir receptacle can be formed on the housing either adjacent to the air inlet opening or to the air outlet opening.
  • gear rims corresponding to one another can be formed on the facing end faces of the cartridge and the rotary element, so that the corresponding End faces of the cartridge and of the rotary element can be releasably brought into engagement with one another, whereby in the engaged state when the rotary element is rotated, the cartridge is rotated along with it.
  • the cartridge can be designed to be refillable.
  • the housing of the aerosol dispenser and / or the components arranged therein and / or the cartridge can be made of disinfectable materials, such as metals or plastics, so that repeated use is possible.
  • the present invention thus provides an aerosol dispenser for a ventilator which can be produced simply and inexpensively and is simple and user-friendly to handle.
  • the invention proposes a corresponding ventilator, which comprises a ventilation unit for generating ventilation air and a user interface that is configured for invasive or non-invasive ventilation of a person, the ventilation unit and the user interface through a ventilation line for supplying Ventilation air are coupled to a patient with one another, an adjustable aerosol dispenser according to the present invention being attached between the ventilation unit and the user interface in a ventilation air flow.
  • the air inlet opening of the aerosol dispenser is here connected to a hose coming from the ventilation unit, so that the air generated by the ventilation unit can flow into the aerosol dispenser, the air outlet opening of the aerosol dispenser being connected to a hose going to the user interface so that the in the aerosol dispenser with a Ventilation air enriched with the active ingredient can be directed to the patient.
  • FIG. 1 is a schematic view of a cartridge assembly according to the present invention
  • FIG. Figure 2 is a schematic cross-sectional view of the cartridge assembly in accordance with the present invention.
  • FIG. 3 is a schematic view of a housing according to a preferred one
  • Embodiment of the invention in which the drug reservoir intake extends through the entire housing and has an opening at both ends, with a rotary element and a closing cover for airtight closing of the openings are also shown,
  • FIG. 4 is a schematic view of an aerosol dispenser mounted on a ventilator according to the present invention without a cartridge;
  • FIG. 5 is a schematic view of an application state of an on a
  • Ventilator-mounted aerosol dispenser according to the present invention, the supplementary administration of an active ingredient being realized in aerosol form, and
  • FIG. 6A to 6C are a schematic cross-sectional view of various relative
  • FIG. 5 comprises an adjustable aerosol dispenser according to the invention for a ventilator, an active substance reservoir 1 and a housing 2.
  • the housing 2 can be a body with a rectangular, round or oval cross-section which has a certain length L.
  • the housing 2 is essentially cylindrical, ie a body with a round cross-section.
  • the housing 2 is designed in the form of a flea body 21, so that a receiving space is defined inside the housing 2, the housing 2 having an air inlet opening 23 and an air outlet opening 24, which are located on two opposite sides of the housing 2 are trained.
  • the receiving space of the housing 2 can communicate with the outside environment via the air inlet opening 23 and the air outlet opening 24.
  • the air inlet opening 23 and the air outlet opening 24 are each configured for coupling to a corresponding ventilation hose 5a, 5b.
  • a corresponding adapter (not shown) can optionally be provided so that the air inlet opening 23 and the air outlet opening 24 can be connected to conventional ventilation hoses 5a, 5b with different diameters.
  • an air flow space is formed in the receiving space of the housing 2 between the air inlet opening 23 and the air outlet opening 24, an air flow direction pointing in the direction of the air outlet opening 24 and being defined along the length L of the housing 2.
  • the housing 2 is also characterized in that an active substance reservoir receptacle 22 is provided in its receiving space, which is configured for attaching an active substance reservoir.
  • the active ingredient reservoir receptacle 22 is designed as a kanalförmi ger space which extends parallel to the air flow direction. More precisely, the active substance reservoir receptacle 22 is delimited by a peripheral wall 25 which has a peripheral wall opening.
  • the circumferential wall 25 separates the inside of the active ingredient reservoir receptacle 22 from the rest of the receiving space of the housing 2, whereas the active ingredient reservoir receptacle 22 communicates with the receiving space of the housing 2 through the circumferential wall opening, so that the active ingredient reservoir receptacle 22 via the receiving space of the housing 2 with the air inlet opening 23 and the air outlet opening 24 can communicate.
  • the peripheral wall opening can be designed as an open area or as a permeable material layer in the peripheral wall of the active substance reservoir receptacle 22.
  • the housing 2 is preferably made of a plastic, but can also be made of another suitable material.
  • the drug reservoir 1 is designed accordingly in the form of a cartridge which has an essentially cylindrical basic shape so that it can be accommodated appropriately in the drug reservoir receptacle 22.
  • An active substance receiving space 16 is defined in the interior of the cartridge, which is delimited by an upper and lower end face and a lateral surface, the active substance receiving space 16 serving to receive an active substance and an active substance carrier 14.
  • the jacket surface of the cartridge 1 has a first closed jacket surface wall area 13 and a cartridge opening 15.
  • the first closed jacket surface wall area 13 tightly encloses the active substance receiving space 16, whereas the cartridge opening 15 is designed in such a way that the active substance receiving space 16 can be exchanged with the environment, in particular gas (ventilation air) can penetrate into the active substance receiving space 16 from the outside and an aerosol formed can escape.
  • the cartridge opening 15 can be designed as a partially permeable material layer (membrane) or as a lattice structure (e.g. wall with a large number of holes) in the surface of the cartridge.
  • the cartridge opening 15 is defined in the jacket surface in the form of a cylinder sector of the cartridge 1 with an arc of a circle R, the peripheral wall opening being defined in the jacket surface of the drug reservoir receptacle 22 in the form of a cylinder sector, with a respective opening angle ⁇ of the cartridge opening 15 and the peripheral wall opening is a maximum of 180 °, the closed surface area wall region 13 and the closed circumferential wall 25 correspondingly cover the remaining surface area of the cartridge 1 and the active ingredient reservoir voir receptacle 22.
  • the cartridge 1 is configured for attachment in the drug reservoir receptacle 22. Accordingly, the dimensions of the cartridge 1 and the active ingredient reservoir voir receptacle 22 are matched to one another.
  • the cylindrical space of the drug reservoir receptacle 22 is at least one end open on the outside, the active substance reservoir receptacle 22 being provided with an upper opening 222 and / or a lower opening 221 on the housing 2 for this purpose.
  • the at least one opening 221, 222 is hermetically sealed by an airtight element which is detachably connected to the housing 2, a rotating element 4 being provided as an airtight element to close one of the openings 221, 222 to close.
  • the rotary element 4 is rotatable relative to the housing 2 and can be provided with markings which define a first or second direction of rotation.
  • the facing end faces of the cartridge 1 and the rotary element 4 are therefore formed with corresponding toothed rims 11, by means of which the corresponding end faces of the cartridge 1 and the rotary element 4 can be releasably brought into engagement with one another.
  • the cylindrical space of the active ingredient reservoir receptacle 22 is open to the outside at both ends, the active ingredient reservoir receptacle 22 being provided with an upper opening 222 at the upper end and a lower opening 221 at the lower end, the upper opening 222 through a releasably connected rotary element 4 is tightly closed ver, wherein a closure cover 3 is also provided as an airtight element for closing the lower opening 221, which is releasably connected to the lower opening 221.
  • closure cover 3 can be screwed, for example via a corresponding threaded section, to the lower end of the active substance reservoir receptacle 22 in order to close the lower opening 221.
  • a suitable sealing ring can also be used to achieve a better sealing effect.
  • the length of the active substance reservoir receptacle 22 in the preferred embodiment shown corresponds to the length L of the housing 2
  • each of the Openings 221, 222 of the active ingredient reservoir receptacle 22 on the housing 2 are either formed adjacent to the air inlet opening 23 or air outlet opening 24, with the upper opening 222 preferably being adjacent to the air inlet opening 23 and the lower opening to the air outlet opening 24.
  • the aerosol dispenser according to the invention is intended for use in a respirator which comprises a ventilation unit for generating ventilation air and a user interface which is configured for invasive or non-invasive ventilation of a person, the ventilation unit and the user interface being provided by an inhalation tube 5a, 5b are coupled to one another for supplying ventilation air to a patient.
  • the fully controllable aerosol dispenser according to the invention is placed between the ventilation unit and the user interface, for this purpose the air inlet opening 23 is connected to a hose 5a coming from the ventilation unit, so that the air generated by the ventilation unit can flow into the aerosol dispenser, the air outlet opening 24 is connected to a hose 5b going to the user interface, so that the ventilation air enriched with an active ingredient in the aerosol dispenser can be conducted to the patient.
  • the ventilation unit can be a conventional ventilation system, e.g. a conventional CPAP machine.
  • the user interface is a verbun device with the respiratory organs of a patient for non-invasive ventilation, for example a breathing mask, or invasive ventilation (by means of intubation).
  • the housing 2 of the aerosol dispenser according to the invention can be permanently connected to the ventilation tubes 5a, 5b and be coupled between a ventilation unit and a user interface. If the supplementary administration of an active ingredient in aerosol form is to be rea lized for therapy, a cartridge 1 carrying a desired active ingredient is inserted into the active ingredient reservoir receptacle 22. An opening 222 of the active ingredient reservoir jur receptacle 22 is closed by the rotary element 4, the rotary element 4 also being brought into engagement with the cartridge 1 in such a way that it is rotated synchronously with a rotation of the rotary element 4. The lower opening 221 of the drug reservoir receptacle 22 is tightly closed by a closure cover 3. By removing the lower opening 221, a user can let the cartridge 1 fall out in a controlled manner and thus easily remove it if necessary.
  • the air generated by a ventilation unit flows through the air inlet opening 23 from a hose 5a coming from the ventilation unit into the receiving space of the housing 2 of the aerosol dispenser, the air being swirled in the receiving space and flowing around the cartridge.
  • the air is then directed to the patient via the air outlet opening 24 and a hose 5b going to the user interface. If the air can communicate with the active ingredient carrier 14 received therein as it flows around the cartridge 1, an aerosol containing the active ingredient can form.
  • the active substance intensity in the aerosol can be regulated gradually and precisely by various relative positions of the cartridge 1 in the active substance reservoir receptacle 22.
  • the opening angle ⁇ of the cartridge opening 15 and the peripheral wall opening are each 90 °.
  • the cartridge 1 is rotated with respect to the active substance reservoir receptacle 22 in such a way that the areas of the cartridge opening 15 and the circumferential wall opening completely correspond to one another.
  • the active ingredient carrier 14 is exposed to the maximum via the cartridge opening 15 and the circumferential wall opening in relation to the receiving space of the housing 2, so that for a certain flow rate of ventilation air through the housing 2, a maximum Interaction of the air flow with the active substance carrier 14 is realized and the active substance intensity in the aerosol formed is consequently high.
  • the cartridge 1 is slightly rotated with respect to the active substance reservoir receptacle 22, so that the areas of the cartridge opening 15 and the opening in the peripheral wall only partially overlap.
  • the active ingredient carrier 14 is only exposed over the reduced overlap area of the cartridge opening 15 and the circumferential wall opening in relation to the receiving space of the housing 2, so that for a certain flow rate of ventilation air through the housing 2, there is less interaction of the air with the active ingredient carrier 14 is realized and the active substance intensity in the aerosol formed compared to the state in FIG. 6A is reduced.
  • the cartridge 1 is completely rotated with respect to the active substance reservoir receptacle 22, so that the areas of the cartridge opening 15 and the peripheral wall opening no longer overlap one another.
  • the active substance carrier 14 is shielded with respect to the receiving space of the housing 2, so that the ventilation air flowing through the housing 2 no longer interacts with the active substance carrier 14.
  • the relative position of the cartridge 1 in the active substance reservoir receptacle 22 can be changed quickly and easily by rotating the rotary element 4 in order to adapt the active substance intensity in the aerosol.
  • the active ingredient intensity can be regulated gradually or continuously and precisely by the degree of exposure of the active ingredient carrier 14 in the air stream.
  • the cartridge 1 is preferably made of a plastic, e.g. polypropylene, but can also be made of another suitable material, e.g. glass or metal, be made. In the preferred embodiments, the cartridge 1 is refillable. It should be noted that the cartridges 1 are easy to manufacture and can be distributed by the device manufacturer himself or can be sold by other suppliers, for example pharmaceutical companies.
  • the cartridge 1 can be 3 to 10 cm, preferably between 5 and 8 cm, long and have a diameter between 0.5 and 3 cm, preferably between 1 and 2.5 cm.
  • the active substance receiving space 16 of the cartridge 1 serves to receive an active substance carrier 14, the active substance carrier 14 preferably being a solid carrier matrix soaked with an active substance solution.
  • the carrier matrix can be a nonwoven material or wick, for example made of cotton, but the present invention is not limited thereto.
  • the active ingredient taken up on the carrier matrix, from which an aerosol is to be formed can be any known active compound for inhalative use or use in ventilation therapy, or a combination thereof.
  • active compounds are plant extracts or ingredients such as essential oils (preferably menthol, levomenthol, camphor), anti-inflammatory compounds, decongestant compounds or agents against infections.
  • the active substance absorbed on the carrier matrix can be a standard solution or have an individual composition specially designed by a specialist for a patient.
  • a ventilator equipped with it can be a CPAP device for home therapy for sleep apnea, whereby the user can use a suitable cartridge (e.g. composition with menthol or the like (as with commercially available inhalation pens)) for independent short-term therapy for mild respiratory diseases, such as runny nose.
  • a suitable cartridge e.g. composition with menthol or the like (as with commercially available inhalation pens)
  • mild respiratory diseases such as runny nose.
  • a ventilator equipped with the aerosol dispenser according to the invention is also suitable for the short-term therapy of respiratory diseases (such as bronchitis) as a substitute for conventional inhalation therapy, whereby completely new therapeutic effects are made possible by the long duration of action (e.g. use of a ventilator over the entire duration of sleep) .
  • the longer active ingredient disposition can, for example, reduce the dose of active ingredient required.
  • a ventilator equipped with the aerosol dispenser according to the invention is also suitable for supporting pre- / postoperative use or for treating or relieving the symptoms of chronic lung diseases (such as asthma, COPD) due to the additional application of active ingredients.
  • homeopathic and wellness applications are also conceivable (e.g. with lavender oil with a calming effect).
  • the cartridge 1 is arranged parallel to the direction of air flow in the housing 2, the air flow through the cartridge 1 is not mechanically hindered or blocked, so that the ventilation air can flow through the aerosol dispenser unhindered. Furthermore, the air portion enriched with active ingredient mixes along the air flow direction with the remaining air flowing through the housing, which prevents unwanted separation of the aerosol on dispenser components, which improves the efficiency of the drug administration.
  • the structure of the aerosol dispenser according to the invention is simple, the cartridges and the housing components causing low manufacturing costs.
  • the structure of the aerosol dispenser according to the invention enables it to be integrated into all conventional ventilation systems, so that, for example, "simpler" CPAP devices (e.g. without a water tank) can be retrofitted and used therapeutically without great effort.
  • the intensity of the active ingredients in the aerosol can be easily and precisely regulated using a simple rotating mechanism. 5.
  • a cartridge 1 can be easily attached in the housing 2 and can be replaced if necessary, so that the aerosol dispenser according to the invention can be used flexibly and is environmentally friendly (since only the cartridges need to be replaced or refillable cartridges can be used).

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Anesthesiology (AREA)
  • Biomedical Technology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Hematology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Emergency Medicine (AREA)
  • Pulmonology (AREA)
  • Containers And Packaging Bodies Having A Special Means To Remove Contents (AREA)

Abstract

La présente invention concerne un distributeur d'aérosol réglable pour un appareil de ventilation destiné à fournir un principe actif dans l'air de ventilation ainsi qu'un appareil de ventilation correspondant, le distributeur d'aérosol comprenant un boîtier (2) et un réservoir de principe actif (1), le boîtier (2) comportant une ouverture d'entrée d'air (23) et une ouverture de sortie d'air (24) opposée à l'ouverture d'entrée d'air (23), lesquelles sont respectivement conçues pour être accouplées à une conduite de ventilation (5a, 5b), l'ouverture d'entrée d'air (23) et l'ouverture de sortie d'air (24) étant en communication avec le réservoir de principe actif (1), de sorte que l'air de ventilation, qui s'écoule dans le boîtier (2) entre l'ouverture d'entrée d'air (23) et l'ouverture de sortie d'air (24), peut s'écouler devant le réservoir de principe actif (1) et/ou peut s'écouler à travers le réservoir de principe actif (1), le réservoir de principe actif (1) étant une cartouche qui est agencée, de façon remplaçable, dans le boîtier (2) dans un logement de réservoir de principe actif (22), la cartouche délimitant un espace de logement de principe actif (16) destiné à loger le principe actif à fournir, lequel comporte une ouverture de cartouche destinée à la distribution du principe actif, le distributeur aérosol comprenant un dispositif de fermeture destiné à la fermeture partielle par étapes ou en continu de l'ouverture de cartouche et ainsi la commande d'une dose de distribution du principe actif.
PCT/EP2020/057701 2019-04-05 2020-03-19 Distributeur d'aérosol réglable destiné à un appareil de ventilation et appareil de ventilation comportant ce dernier WO2020200830A1 (fr)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE102019109000.8A DE102019109000A1 (de) 2019-04-05 2019-04-05 Einstellbarer Aerosoldispenser für ein Beatmungsgerät und Beatmungsgerät mit demselben
DE102019109000.8 2019-04-05

Publications (1)

Publication Number Publication Date
WO2020200830A1 true WO2020200830A1 (fr) 2020-10-08

Family

ID=70227987

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/EP2020/057701 WO2020200830A1 (fr) 2019-04-05 2020-03-19 Distributeur d'aérosol réglable destiné à un appareil de ventilation et appareil de ventilation comportant ce dernier

Country Status (2)

Country Link
DE (1) DE102019109000A1 (fr)
WO (1) WO2020200830A1 (fr)

Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20080078382A1 (en) * 2006-09-20 2008-04-03 Lemahieu Edward Methods and Systems of Delivering Medication Via Inhalation
WO2016139645A1 (fr) * 2015-03-05 2016-09-09 Resmed Limited Humidificateur pour dispositif de thérapie respiratoire
WO2018198081A1 (fr) * 2017-04-27 2018-11-01 Fisher & Paykel Healthcare Limited Dispositif et système d'humidification

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
RU2189837C1 (ru) * 2001-07-02 2002-09-27 Мишустин Юрий Николаевич Аппарат для формирования физиологически активной дыхательной среды из выдохнутого и атмосферного воздуха
US20130312749A1 (en) * 2012-05-22 2013-11-28 LifeSense Technologies, LLC Method and apparatus to enable inhalation of air of varied temperature with or without aromatic conditioning
US10682487B2 (en) * 2015-02-08 2020-06-16 Cpap Infusion, Llc Scent delivery adaptor for CPAP

Patent Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20080078382A1 (en) * 2006-09-20 2008-04-03 Lemahieu Edward Methods and Systems of Delivering Medication Via Inhalation
WO2016139645A1 (fr) * 2015-03-05 2016-09-09 Resmed Limited Humidificateur pour dispositif de thérapie respiratoire
WO2018198081A1 (fr) * 2017-04-27 2018-11-01 Fisher & Paykel Healthcare Limited Dispositif et système d'humidification

Also Published As

Publication number Publication date
DE102019109000A1 (de) 2020-10-08

Similar Documents

Publication Publication Date Title
DE60121144T2 (de) Eine inhalationsvorrichtung
DE69511102T2 (de) Wiederbelebungsgerät
DE69729071T2 (de) Vernebler
DE69424310T2 (de) Pulverinhalator
EP1258264B1 (fr) Appareil pour l'administration d'aérosol
DE69607143T2 (de) Inhalator
DE69329775T2 (de) Zerstäuber mit geringer durchsatzrate
EP1474195B1 (fr) Appareil auxiliaire d'inhalation
EP3548127B1 (fr) Unité de nébulisation munie d'une ampoule pouvant être raccordée directement
EP0747076A2 (fr) Appareil de nébulisation de fluides
EP0009667A1 (fr) Appareil inhalateur
WO2001032246A1 (fr) Vaporisateur d'inhalation
EP2709702B1 (fr) Crayon d'inhalation
EP3297762A1 (fr) Dispositif d'inhalation, agencement de dispositif d'inhalation et plaque d'injecteur associée
EP1107809A1 (fr) Inhalateur pour nebuliser des liquides
DE102019109079B4 (de) Aerosol-Dispersionseinrichtung
WO2020200830A1 (fr) Distributeur d'aérosol réglable destiné à un appareil de ventilation et appareil de ventilation comportant ce dernier
EP3323455B1 (fr) Dispositif d'inhalation de brouillard de gouttelettes
DE29509286U1 (de) Vorrichtung zum Vernebeln von Fluiden
EP2979718B1 (fr) Chambre d'inhalation dotée d'élément de commande pour inhalateur
DE19902845C1 (de) Medikamentenvernebler mit verbessertem Medikamentenzuführkanal
DE2124651B2 (de) Befeuchtungs- und vernebelungsgeraet fuer heilzwecke
DE3333388A1 (de) Inhalationsstift
DE202015003981U1 (de) Kompakter Zerstäuber zur Inhalation von Wirkstoffe für die Anwendung in der Tiermedizin
DE102022121402A1 (de) Strömungsoptimiertes Mundstück mit Luftspalt für einen Inhalator

Legal Events

Date Code Title Description
121 Ep: the epo has been informed by wipo that ep was designated in this application

Ref document number: 20717779

Country of ref document: EP

Kind code of ref document: A1

122 Ep: pct application non-entry in european phase

Ref document number: 20717779

Country of ref document: EP

Kind code of ref document: A1